≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Ankylosis of joint

DOID EFO Endpoint Browser PheWeb

M13_ANKYLOSISJOINT

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M24.6
  • Hospital discharge: ICD-9 — 7185
  • Hospital discharge: ICD-8 — 727
  • Cause of death: ICD-10 — M24.6
  • Cause of death: ICD-9 — 7185
  • Cause of death: ICD-8 — 727

2 out of 7 registries used, show all original rules.

206

4. Check minimum number of events

None

206

5. Include endpoints

None

206

6. Filter based on genotype QC (FinnGen only)

206

Control definitions (FinnGen only)

Control exclude
M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M24
Name in latin
Ancylosis articulationis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2284 1149 1101
Only index persons 1575 851 724
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.03
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 50.86 50.73 50.88
Only index persons 45.49 46.78 43.99

-FinnGen-

Key figures

All Female Male
Number of individuals 206 107 99
Unadjusted period prevalence (%) 0.04 0.04 0.04
Median age at first event (years) 46.31 45.20 47.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
190
Matched controls
1899
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M24.6
ICD-10 Finland
Ankylosis of joint
+∞
97.5
85
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
36.3
36.8
47
17
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
28.9
27
*
72710
ICD-8 Finland
Ankylosis of joint, Of shoulder
+∞
27.8
26
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
149.6
25.3
26
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
20.3
17.0
25
14
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
49.4
15.3
18
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
11.9
14.8
27
26
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
29.9
14.6
19
7
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
53.9
13.0
15
*
72700
ICD-8 Finland
Ankylosis of joint, Of spine
+∞
12.6
12
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
50.0
12.0
14
*
M09AX01
ATC
hyaluronic acid; parenteral
23.1
10.9
15
7
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
9.7
10.6
21
24
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
10.5
10
*
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
+∞
10.5
10
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
+∞
10.5
10
*
NGT60
NOMESCO Finland
Forcible manipulation of knee joint
+∞
10.5
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
3.5
10.1
53
188
N03AX12
ATC
gabapentin; oral
4.5
9.7
35
90
72799
ICD-8 Finland
Ankylosis of joint, Of unspecified site
+∞
9.4
9
*
NF1AA
NOMESCO Finland
Hip X-ray examination
6.4
8.9
23
40
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
52.4
8.8
10
*
B01AB05
ATC
enoxaparin; parenteral
2.9
8.7
60
257
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.1
8.6
34
96
NDE60
NOMESCO Finland
Incision and release of adhesions in joint of finger or metacarpal
94.0
8.5
9
*
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
94.0
8.5
9
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
8.3
84
449
M01AX05
ATC
glucosamine; oral
3.5
8.3
40
133
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
35.0
8.2
10
*
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
15.9
7.8
12
8
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
10.7
7.7
14
14
M25.5
ICD-10 Finland
Pain in joint
3.3
7.6
41
146
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
7.5
67
331
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
7.4
7.5
17
25
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
+∞
7.3
7
*
72770
ICD-8 Finland
Ankylosis of joint, Of ankle
+∞
7.3
7
*
L15
ICPC
Knee symptom/complaint
3.5
7.3
34
110
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
7.1
7.3
17
26
N02AX02
ATC
tramadol; systemic, rectal
2.4
7.2
80
443
L90
ICPC
Osteoarthrosis of knee
14.5
7.0
11
8
M20.1
ICD-10 Finland
Hallux valgus (acquired)
14.5
7.0
11
8
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.7
6.9
54
247
9253
FHL
Manipulation under anesthesia or regression and plastering
23.5
6.7
9
*
M48.0
ICD-10 Finland
Spinal stenosis
4.0
6.6
26
73
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
15.0
6.5
10
7
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
15.0
6.5
10
7
J01DA01
ATC
[U] cefalexin; systemic
2.2
6.5
119
820
M01AH05
ATC
etoricoxib; oral
2.2
6.4
91
556
R51.80
ICD-10 Finland
Headache
3.2
6.4
33
116
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.6
6.4
11
10
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
6.4
57
280
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
+∞
6.3
6
*
72760
ICD-8 Finland
Ankylosis of joint, Of knee
+∞
6.3
6
*
9294
FHL
Endoprosthesis replacement of the entire hip joint (eg Charnley)
+∞
6.3
6
*
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
27.7
6.3
8
*
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
13.1
6.2
10
8
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
13.1
6.2
10
8
1220
FHL
Arthroscopy
10.5
6.1
11
11
M01AH01
ATC
celecoxib; oral (coxibs)
3.0
6.1
37
143
M01AX17
ATC
nimesulide; oral
2.5
6.0
49
228

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
140
2.71
5.91
1.2
1.1
u/ml
1.2
1.3
—
7
60
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
88
579
1.91
4.78
2.4
2.2
nmol/l
74.3
76.4
0.25
76
507
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
166
2.34
4.52
1.3
1.2
iu/ml
11.8
16.1
0.54
11
52
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
101
745
1.70
3.44
6.2
6.1
mmol/l
1.2
1.2
0.55
88
638
(3013707) Erythrocyte sedimentation rate by Westergren method
128
1010
1.71
3.36
4.1
3.4
mm/h
13.8
12.2
0.53
118
914
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
79
570
1.63
2.79
2.3
1.9
pmol/l
84.1
92.4
0.88
38
294
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
61
417
1.66
2.64
2.6
2.1
u/l
291.0
228.2
0.21
56
393
(3024561) Albumin [Mass/volume] in Serum or Plasma
85
633
1.58
2.60
4.6
4.2
g/l
35.4
35.2
0.14
79
591
(3019225) pH of Specimen
27
148
1.95
2.43
7.0
4.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
179
1.86
2.39
9.1
8.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
66
2.37
2.30
2.7
2.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
45
295
1.67
2.27
1.3
1.2
u/ml
11.1
1.0
0.67
11
79
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
24
3.42
2.20
1.4
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
46
307
1.64
2.16
2.6
2.6
umol/l
370.2
15420.3
3.10
38
258
(3004588) Protein electrophoresis panel - Serum or Plasma
18
90
2.10
2.07
1.1
2.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
61
441
1.54
2.05
3.4
4.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
173
1.79
2.03
1.3
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
28
166
1.79
2.00
2.4
2.2
%
18.2
23.9
1.85
23
138
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
72
2.17
1.91
1.1
1.6
—
45.8
—
0
6
(3001122) Ferritin [Mass/volume] in Serum or Plasma
73
556
1.48
1.91
2.8
2.4
ug/l
147.0
116.0
0.58
66
505
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
49
343
1.56
1.89
2.1
1.8
mg/l
2.5
3.2
1.39
41
290
(3009214) Lutropin [Units/volume] in Serum or Plasma
8
28
2.93
1.88
1.4
1.2
u/l
6.7
6.4
—
8
21
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
61
452
1.50
1.81
3.0
3.0
ng/l
1637.3
1446.6
0.19
53
386
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
40
272
1.58
1.74
1.4
1.5
mg/l
0.7
1.2
1.64
35
203
(1761868) Lipid panel - Serum or Plasma
36
516
0.63
1.70
3.3
3.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
124
1062
1.42
1.66
4.9
3.7
pmol/l
15.3
14.9
0.93
112
952
(3025941) Bacteria identified in Stool by Culture
14
71
2.04
1.58
1.3
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
139
1.74
1.56
2.1
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
25
157
1.67
1.49
1.2
2.4
ug/g
85.4
152.4
1.05
16
122
(3007164) IgA [Mass/volume] in Serum or Plasma
38
265
1.53
1.49
1.2
1.4
g/l
2.5
2.5
0.05
19
165
(3013115) Eosinophils [#/volume] in Blood
85
692
1.39
1.48
4.1
5.1
e9/l
0.2
0.2
0.01
73
594
(3013512) EKG study
56
428
1.42
1.39
4.2
3.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
76
614
1.38
1.37
3.9
3.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
77
624
1.37
1.36
4.4
5.3
%
8.1
8.9
1.31
70
576
(3042936) Bacteria identified in Isolate by Culture
25
163
1.61
1.30
2.1
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
18
2.82
1.29
1.0
1.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
76
620
1.36
1.28
4.3
5.1
%
2.9
2.8
0.07
67
567
(3019198) Lymphocytes [#/volume] in Blood
82
678
1.35
1.26
4.0
5.0
e9/l
1.8
1.8
0.03
71
589
(3002030) Lymphocytes/100 leukocytes in Blood
78
640
1.35
1.26
4.3
5.2
%
26.7
26.8
0.03
71
588
(3001604) Monocytes [#/volume] in Blood
80
660
1.35
1.25
4.0
5.0
e9/l
0.6
0.6
0.17
68
561
(3006315) Basophils [#/volume] in Blood
80
663
1.34
1.20
4.2
4.9
e9/l
0.0
0.0
0.47
68
566
(3023368) Bacteria identified in Blood by Culture
53
412
1.39
1.19
3.5
3.9
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
11
57
1.98
1.19
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
148
1345
1.36
1.16
6.0
5.8
mmol/mol
39.7
40.6
0.62
140
1228
(3021589) Normoblasts [#/volume] in Blood
50
630
0.73
1.15
7.2
8.2
e9/l
0.0
0.0
1.14
41
502
(3041096) Erythrocytes [Presence] in Urine by Automated
29
401
0.68
1.13
3.2
3.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
76
631
1.32
1.12
4.0
5.0
%
58.9
57.9
0.29
68
583
(40761535) Cells panel - Urine sediment
21
139
1.57
1.05
3.1
3.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
70
579
1.32
1.05
5.1
3.9
ng/l
35.7
52.6
0.56
57
429
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
42
321
1.39
1.04
2.3
2.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
22
2.30
1.04
1.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
48
1.91
1.02
1.4
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
29
0.00
0.98
0.0
2.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
50
1.84
0.98
1.1
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
36
1.98
0.98
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
72
605
1.29
0.95
4.4
5.1
%
0.6
0.7
0.85
66
551
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
37
1.92
0.95
1.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
27
2.26
0.94
1.8
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
136
1.52
0.90
1.3
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
27
197
1.43
0.88
6.2
4.1
%
35.0
31.8
0.53
21
130
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
31
1.96
0.85
1.0
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
105
935
1.25
0.84
3.4
2.8
u/l
56.0
47.4
0.42
96
860
(3049717) Cytology report of Urine Cyto stain
8
46
1.77
0.83
2.0
2.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
32
1.90
0.82
1.2
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.2
—
12.3
—
0
17
(3019309) Folate [Moles/volume] in Red Blood Cells
37
291
1.33
0.78
1.9
1.6
nmol/l
1127.4
1178.5
0.14
29
221
(3021960) Folate [Moles/volume] in Serum or Plasma
42
338
1.30
0.76
1.7
1.5
nmol/l
27.5
20.7
0.62
36
275
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
54
1.70
0.75
1.7
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
54
1.70
0.75
1.0
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
91
805
1.23
0.75
2.5
2.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
23
168
1.42
0.75
1.3
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
97
864
1.23
0.75
3.9
4.4
mmol/l
6.4
6.9
1.43
90
816
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
123
1124
1.23
0.75
6.9
7.0
u/l
78.4
82.3
0.41
118
1050
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
45
368
1.29
0.73
1.5
1.6
mmol/l
1.5
1.3
0.82
39
291
(3032080) INR in Blood by Coagulation assay
71
615
1.24
0.71
8.0
8.1
inr
1.4
1.3
0.28
15
172
(3008898) HLA-B27 [Presence]
5
26
1.95
0.71
1.2
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
90
800
1.22
0.70
6.6
8.7
e9/l
4.4
4.2
0.46
76
686
(36660697) Celiac disease serology panel - Serum
14
94
1.53
0.68
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
86
1.55
0.68
1.5
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
44
1.61
0.66
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
44
1.61
0.66
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
44
1.61
0.66
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
29
1.74
0.64
1.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
29
1.74
0.64
1.2
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
30
1.68
0.62
1.0
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
30
238
1.30
0.61
1.7
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
20
0.00
0.60
0.0
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
21
0.00
0.60
0.0
3.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
64
1.59
0.59
1.5
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
84
754
1.19
0.57
5.0
6.3
umol/l
9.9
12.5
2.23
79
722
(3018418) pH of Serum or Plasma
54
465
1.22
0.57
3.5
3.9
ph
7.4
7.4
—
6
81
(3026008) Bacteria identified in Urine by Culture
54
465
1.22
0.57
2.9
3.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
123
0.64
0.56
1.3
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
141
1326
1.20
0.56
5.9
4.3
mu/l
1.9
2.8
0.53
130
1190
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
37
1.64
0.56
1.7
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
6
37
1.64
0.56
1.5
1.3
iu/l
6.9
34.4
—
6
30
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
14
99
1.44
0.55
5.9
3.1
mmol/l
1.4
1.9
—
9
79
(3011397) Hemoglobin [Presence] in Urine by Test strip
38
319
1.23
0.51
4.2
3.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
48
414
1.21
0.50
3.0
3.2
mg/l
1379.4
359.0
0.34
35
278
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
45
1.57
0.49
1.0
4.2
mg/l
53.2
50.7
—
7
40
(3005719) IgG [Mass/volume] in Serum or Plasma
14
103
1.39
0.46
1.5
2.5
g/l
10.8
10.0
0.50
14
91
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
84
0.59
0.46
2.0
2.8
%
1.7
1.3
—
5
84
(3044889) 12 lead EKG panel
110
1025
1.16
0.45
4.2
3.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
167
1.29
0.44
1.6
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
31
1.63
0.43
1.2
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
31
1.63
0.43
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
96
1.38
0.42
2.8
3.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
32
1.58
0.42
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
32
1.58
0.42
1.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
32
1.58
0.42
1.2
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
323
0.81
0.42
3.6
2.8
ug/l
1.0
0.9
0.02
18
211
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
242
1.23
0.42
2.2
2.7
e6/l
1.4
1.7
0.11
17
125
(3028300) Cannabinoids [Presence] in Urine
5
33
1.53
0.41
1.2
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
59
1.37
0.41
1.8
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
59
1.37
0.41
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
15
0.00
0.41
0.0
2.4
—
32.1
—
0
15
(3051651) Icteric interference index of Serum or Plasma
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.2
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
21
169
1.27
0.40
1.7
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
50
562
0.85
0.40
4.5
3.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
274.9
—
0
13
(3020891) Body temperature
8
61
1.32
0.40
6.3
4.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
80
1.40
0.39
1.9
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
48
424
1.17
0.39
3.0
3.1
mmol/l
7.2
7.5
0.15
42
358
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
36
1.40
0.38
1.0
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
36
1.40
0.38
1.0
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
107
1.33
0.38
2.6
3.1
ml/min/173m2
68.0
65.0
—
5
45
(40761536) Microorganisms panel - Urine sediment
9
121
0.73
0.36
3.9
3.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
59
533
1.15
0.36
2.7
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
105
987
1.13
0.35
4.2
3.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
48
428
1.16
0.35
2.4
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
34
390
0.85
0.35
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
14
177
0.78
0.35
1.2
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
151
1453
1.15
0.35
17.4
13.5
mg/l
24.4
26.5
0.33
120
1111
(3019550) Sodium [Moles/volume] in Serum or Plasma
158
1525
1.15
0.34
19.6
15.9
mmol/l
139.9
139.6
0.73
153
1474
(3023103) Potassium [Moles/volume] in Serum or Plasma
158
1526
1.15
0.34
19.8
16.0
mmol/l
4.0
4.0
0.43
153
1472
(40760892) CBC W Ordered Manual Differential panel - Blood
31
267
1.19
0.34
5.4
5.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
29
249
1.19
0.33
2.2
2.6
e6/l
0.5
1.1
1.34
17
131
(3024354) Oxygen [Partial pressure] in Venous blood
10
131
0.75
0.32
1.8
2.9
kpa
4.0
4.4
—
10
126
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
121
1.26
0.29
1.2
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
32
281
1.16
0.28
3.6
3.5
ng/l
129.3
200.8
0.26
27
226
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
67
1.20
0.26
1.4
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
77
1.31
0.26
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
20
170
1.20
0.25
1.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
147
1425
1.11
0.24
4.8
4.4
mmol/l
5.9
6.0
0.39
133
1294
(3000494) Fungus identified in Specimen by Culture
18
153
1.19
0.23
1.2
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
146
1417
1.10
0.23
4.7
4.3
mmol/l
1.5
1.5
0.20
136
1286
(3021601) Nitrite [Presence] in Urine by Test strip
67
714
0.91
0.23
4.6
5.0
estimate
0.0
0.0
—
8
125
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
39
1.29
0.23
1.8
2.4
mmol/l
23.9
25.2
—
5
34
(1002224) Polysomnography panel
5
42
1.20
0.21
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
11
0.00
0.21
0.0
1.1
—
236.2
—
0
11
(4027681)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
2.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
5.3
—
118.5
—
0
10
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
4.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
1.0
—
0
14
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
14
0.00
0.20
0.0
1.9
—
5.2
—
0
9
(3000330) Specific gravity of Urine by Test strip
10
81
1.25
0.19
2.1
4.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
150
1464
1.09
0.18
5.2
4.9
mmol/l
2.6
2.7
0.95
141
1328
(3000492) Spirometry study
14
119
1.19
0.18
1.4
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
147
1435
1.09
0.17
4.7
4.3
mmol/l
4.5
4.6
0.65
141
1318
(3012544) pH of Venous blood
13
152
0.85
0.17
2.3
3.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
47
439
1.09
0.17
3.8
4.0
mg/mmol
3.0
11.6
2.47
33
292
(3020564) Creatinine [Moles/volume] in Serum or Plasma
159
1558
1.09
0.17
18.4
16.1
umol/l
84.5
80.0
0.52
159
1558
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
68
1.18
0.17
6.4
6.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
77
0.77
0.16
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
156
1529
1.08
0.16
15.9
12.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
6
78
0.76
0.16
7.7
7.3
mmol/l
26.0
24.3
—
6
73
(3022313) Gas panel - Capillary blood
9
80
1.13
0.15
7.7
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
69
721
0.94
0.14
3.9
3.6
estimate
0.0
0.0
—
10
123
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
97
0.82
0.14
1.5
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
139
1362
1.06
0.12
4.2
3.9
mmol/l
1.3
1.2
0.56
130
1232
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
85
1.19
0.12
1.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
114
1.15
0.12
4.5
3.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
16
178
0.89
0.12
5.1
5.6
kpa
5.1
5.0
0.19
16
167
(3027801) Oxygen [Partial pressure] in Arterial blood
16
178
0.89
0.12
5.1
5.6
kpa
11.1
11.6
0.29
16
169
(3019150) Specific gravity of Urine by Refractometry
34
319
1.08
0.11
5.5
3.8
kg/l
1.0
1.0
—
6
46
(3035350) Ketones [Presence] in Urine by Test strip
69
714
0.95
0.10
4.0
3.6
estimate
0.0
0.0
—
10
122
(36304419) Bacteria [Presence] in Urine
41
390
1.06
0.09
2.8
3.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
124
0.88
0.09
1.9
2.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
14
126
1.12
0.09
7.8
5.6
mmol/l
11.7
9.9
0.44
14
117
(40768443) Skin Pathology biopsy report
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
88
1.14
0.08
1.0
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
33
347
0.94
0.08
4.3
7.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
42
438
0.95
0.08
4.4
4.4
%
26.1
22.4
0.59
18
218
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
6
71
0.84
0.08
1.8
4.2
mmol/l
23.1
24.7
—
6
66
(46235355) HIV 1 and 2 tests - Meaningful Use set
19
204
0.92
0.07
1.7
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
52
504
1.04
0.06
3.1
3.7
e6/l
97.4
88.8
0.06
37
357
(3022145) Colonoscopy Study observation
15
161
0.93
0.05
1.1
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
39
403
0.96
0.05
2.8
3.1
e6/l
0.2
0.6
0.93
31
295
(3009542) Hematocrit [Volume Fraction] of Blood
129
1303
0.97
0.04
17.0
14.1
%
38.3
39.9
0.93
82
902
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
190
1.06
0.04
2.0
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
108
0.92
0.03
1.7
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
12
128
0.93
0.02
5.2
6.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
56
570
0.98
0.02
2.5
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
133
1.06
0.01
3.2
3.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
164
1633
1.02
0.01
24.0
19.4
e12/l
4.4
4.5
0.88
159
1570
(3007461) Platelets [#/volume] in Blood
164
1633
1.02
0.01
24.0
19.4
e9/l
248.2
245.7
0.18
159
1572
(3010813) Leukocytes [#/volume] in Blood
164
1634
1.02
0.00
24.1
19.5
e9/l
6.7
6.7
0.02
158
1571
(4010399)
11
114
0.96
0.00
1.7
1.4
—
—
—
0
0
(4035726)
13
129
1.01
0.00
1.2
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
41
406
1.01
0.00
4.7
3.6
estimate
0.0
0.0
—
9
122
(3002582) Erythrocytes [#/volume] in Urine
45
449
1.00
0.00
2.7
3.3
e6/l
31.0
63.0
0.81
37
337
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
138
1377
1.01
0.00
15.0
12.7
ml/min/173m2
76.5
78.1
0.34
112
1126
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
112
0.98
0.00
1.6
1.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
10
95
1.06
0.00
5.9
5.4
mmol/l
24.6
24.2
—
10
89
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
17
168
1.01
0.00
3.4
4.5
ug/l
4.2
68.2
0.97
12
154
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
904.0
—
0
8
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036603) Volume of Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
100.0
—
0
6
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
6.8
—
52.2
—
0
6
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
98.0
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
17.5
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
52
0.96
0.00
1.8
1.7
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.5
—
0
6
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
120
1.00
0.00
1.3
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
136.8
—
0
5
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
2.7
—
13.3
—
0
6
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
12.0
—
0
7
(40757494) Bilirubin.total [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
7.8
—
0
7
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
79
0.88
0.00
1.6
1.9
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
0.9
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ANKYLOSISJOINT and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
M13_ANKYLOSISJOINT 1.198 [0.89, 1.62] 0.241
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 57 out of 285 males with M13_ANKYLOSISJOINT died.

Mortality risk

Mortality risk for people of age

years, who have M13_ANKYLOSISJOINT.

N-year risk Females Males
1 No data 0.302%
5 No data 1.378%
10 No data 3.297%
15 No data 5.964%
20 No data 10.437%

Relationships between endpoints

↥

Index endpoint: M13_ANKYLOSISJOINT – Ankylosis of joint

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data